The Discounted Cash Flow (DCF) valuation of Syros Pharmaceuticals Inc (SYRS) is (140.68) USD. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on DCF is -120138.1%.
Based on the latest price of 0.12 USD and our DCF valuation, Syros Pharmaceuticals Inc (SYRS) is a sell. selling SYRS stocks now will result in a potential gain of 120138.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 37.1% | 21.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5,839.75) - (77.67) | (140.68) |
| Upside | -4982820.9% - -66370.4% | -120138.1% |